Search

Author/Creator Franco, Denise R.

1. Cardiovascular safety of oral semaglutide in patients with type 2 diabetes: Rationale, design and patient baseline characteristics for the PIONEER 6 trial. Issue 3 (11th November 2018)

Authors:
Bain, Stephen C.; Mosenzon, Ofri; Arechavaleta, Rosario; Bogdański, Pawel; Comlekci, Abdurrahman; Consoli, Agostino; Deerochanawong, Chaicharn; Dungan, Kathleen; Faingold, Maria C.; Farkouh, Michael E.; Franco, Denise R.; Gram, Jeppe; Guja, Cristian; Joshi, Pankaj; Malek, Rachid; Merino‐Torres, J...
Journal:
Diabetes, obesity & metabolism
Issue:
Volume 21:Issue 3(2019)
Page Start:
499
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The rate of hyperglycemia and ketosis with insulin degludec‐based treatment compared with insulin detemir in pediatric patients with type 1 diabetes: An analysis of data from two randomized trials. Issue 3 (10th February 2019)

Authors:
Thalange, Nandu; Deeb, Larry; Klingensmith, Georgeanna; Franco, Denise R.; Bardtrum, Lars; Tutkunkardas, Deniz; Danne, Thomas
Journal:
Pediatric diabetes
Issue:
Volume 20:Issue 3(2019)
Page Start:
314
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗